# Epinephrine and Cortisol in Depression

> **NCT04148261** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Depression

## Interventions

- **DRUG:** Hydrocortisone Acetate (CORT)
- **DRUG:** Epinephrine Sulfate (EPI)
- **DRUG:** Placebo (PLB)

## Key facts

- **NCT ID:** NCT04148261
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator left lab before study start
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04148261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04148261, "Epinephrine and Cortisol in Depression". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04148261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*